Vaginal Atrophy (Atrophic Vaginitis) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 39 pages | ID: VA2717C5D17EN
VPAResearch

Abstracts

Vaginal Atrophy (Atrophic Vaginitis) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Vaginal Atrophy (Atrophic Vaginitis) disease clinical trials. The research work analyzes the ongoing Vaginal Atrophy (Atrophic Vaginitis) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Vaginal Atrophy (Atrophic Vaginitis) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Vaginal Atrophy (Atrophic Vaginitis) clinical trials.

Scope of the Report-

• Ongoing Vaginal Atrophy (Atrophic Vaginitis) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Vaginal Atrophy (Atrophic Vaginitis)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Vaginal Atrophy (Atrophic Vaginitis) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Vaginal Atrophy (Atrophic Vaginitis) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Vaginal Atrophy (Atrophic Vaginitis) Trials by Phase
3.2 Ongoing Vaginal Atrophy (Atrophic Vaginitis) Trials by Type
3.3 Ongoing Vaginal Atrophy (Atrophic Vaginitis) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Vaginal Atrophy (Atrophic Vaginitis) Trials
4.2 Top 10 Countries conducting Vaginal Atrophy (Atrophic Vaginitis) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Vaginal Atrophy (Atrophic Vaginitis) Trials by Sponsor Type
5.2 Vaginal Atrophy (Atrophic Vaginitis) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Vaginal Atrophy (Atrophic Vaginitis) Trials by year
6.2 Subjects Recruited for Vaginal Atrophy (Atrophic Vaginitis) Trials by Phase
6.3 Subjects Recruited for Vaginal Atrophy (Atrophic Vaginitis) Trials by Trial Type
6.4 Subjects Recruited for Vaginal Atrophy (Atrophic Vaginitis) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Vaginal Atrophy (Atrophic Vaginitis) Trials- Phase
7.2 Ongoing Vaginal Atrophy (Atrophic Vaginitis) Trials- Phase
7.3 Ongoing Vaginal Atrophy (Atrophic Vaginitis) Trials- Phase
7.4 Ongoing Vaginal Atrophy (Atrophic Vaginitis) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Vaginal Atrophy (Atrophic Vaginitis)- Clinical Trials by Country
Figure 2: Vaginal Atrophy (Atrophic Vaginitis)- Clinical Trials by Phase of Development, 2018
Figure 3: Vaginal Atrophy (Atrophic Vaginitis)- Clinical Trials by Status, 2018
Figure 4: Vaginal Atrophy (Atrophic Vaginitis)- Clinical Trials by Type, 2018
Figure 5: Vaginal Atrophy (Atrophic Vaginitis)- Clinical Trials Split by Region, 2000-2018
Figure 6: Vaginal Atrophy (Atrophic Vaginitis)- Clinical Trials by Type of Economy, 2018
Figure 7: Vaginal Atrophy (Atrophic Vaginitis)- Enrolment by Phase, 2018
Figure 8: Vaginal Atrophy (Atrophic Vaginitis)- Enrolment by Trial Type, 2018
Figure 9: Vaginal Atrophy (Atrophic Vaginitis)- Enrolment by Recruitment Status, 2018
Figure 10: Vaginal Atrophy (Atrophic Vaginitis)- Clinical Trials by Sponsor Type, 2018
Figure 11: Vaginal Atrophy (Atrophic Vaginitis)- Enrolment by Type of Sponsors
Figure 12: Vaginal Atrophy (Atrophic Vaginitis)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Vaginal Atrophy (Atrophic Vaginitis)- Clinical Trials by Sponsor Type, 2018
Table 2: Vaginal Atrophy (Atrophic Vaginitis)- Clinical Trials by Economy Type, 2018
Table 3: Vaginal Atrophy (Atrophic Vaginitis)- Clinical Trials by Region, 2018
Table 4: Vaginal Atrophy (Atrophic Vaginitis)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Vaginal Atrophy (Atrophic Vaginitis)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Vaginal Atrophy (Atrophic Vaginitis)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Vaginal Atrophy (Atrophic Vaginitis)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Vaginal Atrophy (Atrophic Vaginitis)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Vaginal Atrophy (Atrophic Vaginitis)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company